関連する実験動画

Updated: May 4, 2026

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Published on: December 16, 2017

中枢神経系疾患の空間時間的動態:単細胞と空間マルチオミクスによる翻訳神経病理学の進歩

Mingkai Xia¹, Quan Liu¹, Wenli Zhang²

¹Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases College of Integrated Traditional Chinese Medicine and Western Medicine Hunan University of Chinese Medicine Changsha Hunan China.

|August 22, 2025

まとめ

マルチオームプロファイリングと単細胞RNAシーケンシングと空間トランスクリプトミクスを統合することで,複雑な中枢神経系 (CNS) 疾患を理解するための強力なアプローチが提供されます. この方法は,バイオマーカーの発見と精密医療の治療目標の特定を強化します.

科学分野:

神経科学
ゲノミクス
コンピュータ生物学

背景:

中枢神経系 (CNS) 疾患は,世界的に大きな障害と死亡率を引き起こします.
中枢神経系疾患の分子誘導因子の理解は細胞の異質性と細胞間通信の障害によって制限されています
現在の単細胞RNAシーケンシング (scRNA-seq) と空間トランスクリプトミクス (ST) は,価値あるが不完全な洞察を提供します.

研究の目的:

scRNA-seqとSTをマルチオームプロファイリングと統合して,中枢神経疾患の研究の可能性を強調する.
多原子収束がCNSの病理における分子機構と細胞間通信を体系的に解体する方法を示す.
バイオマーカーの発見,患者の分層化,および治療標的の識別を,分子シグネチャと臨床的現象型との相関性によって加速する.

主な方法:

scRNA-seq,ST,およびマルチオームプロファイルの統合
空間的にオーケストラされた分子ネットワークの描写
分子シグネチャーの臨床現象型との相関

主要な成果:

病気に関連したサブ集団とマイクロ環境の改造を明らかにした.
分子機構と細胞間通信の体系的な解明を可能にしました
潜在的バイオマーカーと治療目標の急速な特定

結論:

マルチオミック統合は中枢神経系疾患を理解するための変革的なアプローチを提供します
パーソナライズされた中枢神経系の医学では,データの調和と計算上のスケーラビリティの課題に取り組むことが不可欠です.
マルチオームの洞察を臨床応用に変換するには分野間の枠組みが必要です

キーワード:

中枢神経系疾患分子機構マルチオミクス精密な処理単細胞RNAのシーケンシング空間トランスクリプトミクス

さらに関連する動画

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Published on: March 29, 2024

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

関連する概念動画

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Disorders of the Nervous Tissue

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...